CUSIP: 002120103
Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,757,114
-
Share change
-
+213,904
-
Total reported value
-
$23,128,000
-
Price per share
-
$2.15
-
Number of holders
-
50
-
Value change
-
+$162,662
-
Number of buys
-
20
-
Number of sells
-
18
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2017
-
Previous quarter:
Q3 2016
Recent filing periods for CUSIP 002120103:
Institutional Holders of ATYR PHARMA INC - COM (LIFE) as of Q4 2016
As of 31 Dec 2016,
ATYR PHARMA INC - COM (LIFE) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,757,114 shares.
The largest 10 holders included
FMR LLC, Polaris Venture Management Co. V, L.L.C., Alyeska Investment Group, L.P., EcoR1 Capital, LLC, Rock Springs Capital Management LP, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., TANG CAPITAL MANAGEMENT LLC, BlackRock Advisors LLC, and Glen Harbor Capital Management LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.